Literature Collection

Collection Insights

6K+

References

5K+

Articles

990+

Grey Literature

1800+

Opioids & SU

The Literature Collection contains over 6,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
1801 Results
1
"Feeling confident and equipped": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City
Type: Journal Article
Authors: B. Wolfson-Stofko, M. V. Gwadz, L. Elliott, A. S. Bennett, R. Curtis
Year: 2018
Source:
Wolfson-Stofko B, Gwadz MV, Elliott L, Bennett AS, Curtis R. "Feeling confident and equipped": Evaluating the acceptability and efficacy of an overdose response and naloxone administration intervention to service industry employees in New York City. Drug And Alcohol Dependence 2018;192.
Publication Place: Ireland
Topic(s):
Opioids & Substance Use See topic collection
2
"Hub and Spoke:" Vermont's Framework for Medication Assisted Treatment for Opioid Addiction
Type: Web Resource
Authors: Beth Tanzman, Anthony Folland
Year: 2016
Source:
Tanzman B, Folland A. "Hub and Spoke:" Vermont's Framework for Medication Assisted Treatment for Opioid Addiction 2016.
Abstract: Webinar - Faced with increasing rates of opioid addiction and insufficient treatment capacity to meet demand for care, Vermont developed a novel framework to expand medication assisted treatment in both Opioid Treatment Programs (OTPs) and Office-Based Opioid Treatment (OBOT) settings. Although this initiative initially focuses on medication assisted treatment for individuals with opioid use disorders, it creates a framework for integrating treatment services for other substance abuse issues and co-occurring mental health disorders into the medical home through a managed approach to care. In addition, this treatment approach will help reduce recidivism in corrections and enhance outcomes for families where addiction is an identified problem for child welfare. Note: Viewing of the webinar requires free registration.
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
,
Medical Home See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3
"I'm not abusing or anything": Patient-physician communication about opioid treatment in chronic pain
Type: Journal Article
Authors: Marianne S. Matthias, Erin E. Krebs, Linda A. Collins, Alicia A. Bergman, Jessica Coffing, Matthew J. Bair
Year: 2013
Source:
Matthias MS, Krebs EE, Collins LA, Bergman AA, Coffing J, Bair MJ. "I'm not abusing or anything": Patient-physician communication about opioid treatment in chronic pain. Patient Education And Counseling 2013;93.
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
4
"Painting a picture of the client": implementing the Addiction Severity Index in community treatment programs
Type: Journal Article
Authors: S. E. Spear, A. H. Brown, R. A. Rawson
Year: 2005
Source:
Spear SE, Brown AH, Rawson RA. "Painting a picture of the client": implementing the Addiction Severity Index in community treatment programs. Journal Of Substance Abuse Treatment 2005;29.
Publication Place: United States
Abstract: This article discusses the implementation of the Drug Evaluation Network System (DENS) version of the Addiction Severity Index (ASI) among substance abuse treatment providers in Los Angeles County. Thirty-two trained and certified treatment professionals from 14 programs participated in focus group interviews about their use of and experiences with the ASI. All 14 programs were currently administering the ASI at the time of the study. Qualitative interviews revealed variation among the programs in terms of when staff administered the ASI and how they used it in clinical care. Although the ASI creates a comprehensive picture of substance-abusing patients and their functioning, the timing of its administration seems to significantly affect the usefulness of the information. The findings illustrate the importance of practicality, flexibility, and ongoing training for the successful implementation of evidence-based practices.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
5
'I have it just in case' - Naloxone access and changes in opioid use behaviours
Type: Journal Article
Authors: S. C. Heavey, Y. P. Chang, B. M. Vest, R. L. Collins, W. Wieczorek, G. G. Homish
Year: 2018
Source:
Heavey SC, Chang YP, Vest BM, Collins RL, Wieczorek W, Homish GG. 'I have it just in case' - Naloxone access and changes in opioid use behaviours. The International Journal On Drug Policy 2018;51:27-35, . https://doi.org/10.1016/j.drugpo.2017.09.015.
Publication Place: Netherlands
Topic(s):
Opioids & Substance Use See topic collection
6
'Subutex is safe': Perceptions of risk in using illicit drugs during pregnancy
Type: Journal Article
Authors: Anna Leppo
Year: 2012
Source:
Leppo A. 'Subutex is safe': Perceptions of risk in using illicit drugs during pregnancy. International Journal Of Drug Policy 2012;23:365-373, .
Topic(s):
Opioids & Substance Use See topic collection
7
'This is Not Who I Want to be:' Experiences of Opioid-Dependent Youth Before, and During, Combined Buprenorphine and Behavioral Treatment
Type: Journal Article
Authors: Sarah K. Moore, Honoria Guarino, Lisa A. Marsch
Year: 2014
Source:
Moore SK, Guarino H, Marsch LA. 'This is Not Who I Want to be:' Experiences of Opioid-Dependent Youth Before, and During, Combined Buprenorphine and Behavioral Treatment. Substance Use & Misuse 2014;49:303-314, .
Topic(s):
Opioids & Substance Use See topic collection
8
2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?
Type: Journal Article
Authors: R. Chou
Year: 2009
Source:
Chou R. 2009 Clinical Guidelines from the American Pain Society and the American Academy of Pain Medicine on the use of chronic opioid therapy in chronic noncancer pain: what are the key messages for clinical practice?. Polskie Archiwum Medycyny Wewnetrznej 2009;119:469-477, .
Publication Place: Poland
Abstract: Safe and effective chronic opioid therapy (COT) for chronic noncancer pain requires clinical skills and knowledge in both the principles of opioid prescribing and in the assessment and management of risks associated with opioid abuse, addiction, and diversion. The American Pain Society and the American Academy of Pain Medicine commissioned a systematic review of the evidence on COT for chronic noncancer pain and convened a multidisciplinary expert panel to review the evidence and formulate recommendations based on the best available evidence. This article summarizes key clinical messages from this guideline regarding patient selection and risk stratification, informed consent and opioid management plans, initiation and titration of COT, use of methadone, monitoring of patients, use of opioids in high-risk patients, assessment of aberrant drug-related behaviors, dose escalations and high-dose opioid therapy, opioid rotation, indications for discontinuation of therapy, prevention and management of opioid-related adverse effects, driving and work safety, identifying a medical home and when to obtain consultation, and management of breakthrough pain.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
9
2013 Update in addiction medicine for the generalist
Type: Journal Article
Authors: A. J. Gordon, N. Bertholet, J. McNeely, J. L. Starrels, J. M. Tetrault, A . Y. Walley
Year: 2013
Source:
Gordon AJ, Bertholet N, McNeely J, Starrels JL, Tetrault JM, . Y. Walley A. 2013 Update in addiction medicine for the generalist. Addiction Science & Clinical Practice 2013;8:0640-8-18, 18+. https://doi.org/10.1186/1940-0640-8-18.
Publication Place: England
Abstract: Increasingly, patients with unhealthy alcohol and other drug use are being seen in primary care and other non-specialty addiction settings. Primary care providers are well positioned to screen, assess, and treat patients with alcohol and other drug use because this use, and substance use disorders, may contribute to a host of medical and mental health harms. We sought to identify and examine important recent advances in addiction medicine in the medical literature that have implications for the care of patients in primary care or other generalist settings. To accomplish this aim, we selected articles in the field of addiction medicine, critically appraised and summarized the manuscripts, and highlighted their implications for generalist practice. During an initial review, we identified articles through an electronic Medline search (limited to human studies and in English) using search terms for alcohol and other drugs of abuse published from January 2010 to January 2012. After this initial review, we searched for other literature in web-based or journal resources for potential articles of interest. From the list of articles identified in these initial reviews, each of the six authors independently selected articles for more intensive review and identified the ones they found to have a potential impact on generalist practice. The identified articles were then ranked by the number of authors who selected each article. Through a consensus process over 4 meetings, the authors reached agreement on the articles with implications for practice for generalist clinicians that warranted inclusion for discussion. The authors then grouped the articles into five categories: 1) screening and brief interventions in outpatient settings, 2) identification and management of substance use among inpatients, 3) medical complications of substance use, 4) use of pharmacotherapy for addiction treatment in primary care and its complications, and 5) integration of addiction treatment and medical care. The authors discuss each selected articles' merits, limitations, conclusions, and implication to advancing addiction screening, assessment, and treatment of addiction in generalist physician practice environments.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
10
2014 buprenorphine summit: Report of proceedings
Type: Government Report
Authors: Center for Substance Abuse Treatment
Year: 2014
Source:
Treatment C for SA. 2014 buprenorphine summit: Report of proceedings 2014.
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

11
2016 National Drug Threat Assessment Summary
Type: Government Report
Authors: Drug Enforcement Administration
Year: 2016
Source:
Administration DE. 2016 National Drug Threat Assessment Summary 2016;DEA-DCT-DIR-001-17.
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12
2016 National Survey on Drug Use and Health: Detailed Tables
Type: Government Report
Authors: Center for Behavioral Health Statistics and Quality
Year: 2017
Source:
Quality C for BHS and. 2016 National Survey on Drug Use and Health: Detailed Tables 2017.
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

13
2017 NSDUH Annual National Report
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2018
Source:
Administration SA and MHS. 2017 NSDUH Annual National Report 2018.
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

14
2019 Recommendations of the AMA Opioid Task Force
Type: Report
Authors: AMA Opioid Task Force
Year: 2019
Source:
Force AMAOT. 2019 Recommendations of the AMA Opioid Task Force. American Medical Association; 2019.
Topic(s):
Grey Literature See topic collection
,
Healthcare Policy See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

15
A "middle way": Introducing a flexible year-long program to prepare for certification in addiction medicine
Type: Journal Article
Authors: Petros Levounis, Erin Zerbo, Rashi Aggarwal
Year: 2016
Source:
Levounis P, Zerbo E, Aggarwal R. A "middle way": Introducing a flexible year-long program to prepare for certification in addiction medicine. Academic Psychiatry 2016;40.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
16
A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners
Type: Journal Article
Authors: Ingunn Olea Lund, Svetlana Skurtveit, Monica Sarfi, Brittelise Bakstad, Gabrielle Welle-Strand, Edle Ravndal
Year: 2013
Source:
Lund IO, Skurtveit S, Sarfi M, Bakstad B, Welle-Strand G, Ravndal E. A 2-year prospective study of psychological distress among a national cohort of pregnant women in opioid maintenance treatment and their partners. Journal Of Substance Use 2013;18:148-160, .
Topic(s):
Opioids & Substance Use See topic collection
17
A buprenorphine education and training program for primary care residents: Implementation and evaluation
Type: Journal Article
Authors: H. V. Kunins, N. L. Sohler, A. Giovanniello, D. Thompson, C. O. Cunningham
Year: 2013
Source:
Kunins HV, Sohler NL, Giovanniello A, Thompson D, Cunningham CO. A buprenorphine education and training program for primary care residents: Implementation and evaluation. Substance Abuse 2013;34:242-247, . https://doi.org/10.1080/08897077.2012.752777.
Publication Place: United States
Abstract: BACKGROUND: Although substance use disorders are highly prevalent, resident preparation to care for patients with these disorders is frequently insufficient. With increasing rates of opioid abuse and dependence, and the availability of medication-assisted treatment, one strategy to improve resident skills is to incorporate buprenorphine treatment into training settings. METHODS: In this study, esidency faculty delivered the BupEd education and training program to 71 primary care residents. BupEd included (1) a didactic session on buprenorphine, (2) an interactive motivational interviewing session, (3) monthly case conferences, and (4) supervised clinical experience providing buprenorphine treatment. To evaluate BupEd, the authors assessed (1) residents' provision of buprenorphine treatment during residency, (2) residents' provision of buprenorphine treatment after residency, and (3) treatment retention among patients treated by resident versus attending physicians. RESULTS: Of 71 residents, most served as a covering or primary provider to at least 1 buprenorphine-treated patient (84.5 and 66.2%, respectively). Of 40 graduates, 27.5% obtained a buprenorphine waiver and 17.5% prescribed buprenorphine. Treatment retention was similar between patients cared for by resident PCPs versus attending PCPs (90-day retention: 63.6% [n = 35] vs. 67.9% [n = 152]; P = .55). CONCLUSION: These results show that BupEd is feasible, provides residents with supervised clinical experience in treating opioid-dependent patients, and can serve as a model to prepare primary care physicians to care for patients with opioid dependence.
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
18
A case series of buprenorphine/naloxone treatment in a primary care practice
Type: Journal Article
Authors: B. Doolittle, W. Becker
Year: 2011
Source:
Doolittle B, Becker W. A case series of buprenorphine/naloxone treatment in a primary care practice. Substance Abuse 2011;32:262-265, . https://doi.org/10.1080/08897077.2011.599256.
Publication Place: United States
Abstract: Physicians' adoption of buprenorphine/naloxone treatment is hindered by concerns over feasibility, cost, and lack of comfort treating patients with addiction. We examined the use of buprenorphine/naloxone in a community practice by two generalist physicians without addiction training, employing a retrospective chart review. From 2006-2010, 228 patients with opiate abuse/dependence were treated with buprenorphine/naloxone using a home-induction protocol. Multiple co-morbidities including diabetes (23% of patients), hypertension (36%), Hepatitis C (43%), and depression (74%) were concurrently managed. In this diverse sample, 1/228 experienced precipitated withdrawal during induction. Of the convenience subsample analyzed (n = 28), 82% (+/-10%) had negative urine drug tests for opioids; 92% (+/-11%) were negative for cocaine; 88% (+/-12%) were positive for buprenorphine. This case series demonstrated feasibility and safety of a low-cost buprenorphine/naloxone home induction protocol employed by generalists. Concurrent treatment of multiple comorbidities conforms with the patient-centered medical home ideal. Randomized trials of this promising approach are needed.
Topic(s):
Opioids & Substance Use See topic collection
,
Medical Home See topic collection
19
A chronic opioid therapy dose reduction policy in primary care
Type: Journal Article
Authors: M. B. Weimer, D. M. Hartung, S. Ahmed, C. Nicolaidis
Year: 2016
Source:
Weimer MB, Hartung DM, Ahmed S, Nicolaidis C. A chronic opioid therapy dose reduction policy in primary care. Substance Abuse 2016;37:141-147, . https://doi.org/10.1080/08897077.2015.1129526.
Publication Place: United States
Abstract: BACKGROUND: High-dose opioids prescribed for the treatment of chronic pain have been associated with increased risk of opioid overdose. Health systems and states have responded by developing opioid dose limitation policies. Little is known about how these policies affect prescribing practices or characteristics of patients who respond best to opioid tapers from high-dose opioids. METHODS: We conducted a retrospective cohort study to evaluate change in total opioid dose after the implementation of a provider education intervention and a 120 mg morphine equivalents per day (MED) opioid dose limitation policy in one academic primary care clinic. We compared opioid prescriptions 1 year before and 1 year after the intervention. We used univariate and multivariate logistic regression to assess which patient characteristics predicted opioid dose reduction from high opioid dose. RESULTS: Out of a total of 516 patients prescribed chronic opioid therapy, 116 patients (22%) were prescribed high-dose opioid therapy (>120 mg MED). After policy adoption, the average daily dose of opioids declined by 64 mg MED (95% confidence interval [CI]: 32-96; P < .001) and 41 patients (37%) on high-dose opioids tapered their doses below 120 mg MED (Tapered to Safer Dose group). In multivariate analyses, female sex was the only significant association with dose taper; female patients were less likely to taper to a safer dose (adjusted odds ratio [aOR] = 0.28, 95% CI: 0.11-0.70). CONCLUSIONS: A combined intervention of education and a practice policy that limits opioid doses for patients prescribed chronic opioid therapy may be an important component of system-level strategies to reduce opioid misuse and overdose; it may also help identify patients suitable for medication-assisted treatment for opioid use disorder. Specific strategies may be needed to assist women with opioid dose tapers.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
20
A cognitive behavioral therapy-based text messaging intervention for methamphetamine dependence
Type: Journal Article
Authors: Victoria Keoleian, Alex Stalcup, Douglas L. Polcin, Michelle Brown, Gantt Galloway
Year: 2013
Source:
Keoleian V, Stalcup A, Polcin DL, Brown M, Galloway G. A cognitive behavioral therapy-based text messaging intervention for methamphetamine dependence. Journal Of Psychoactive Drugs 2013;45:434-442, .
Topic(s):
Opioids & Substance Use See topic collection
,
HIT & Telehealth See topic collection